BRPI0721871A2 - Imunoensaios de alta sensibilidade e kits para a determinação de peptídeos e proteínas de interesse biológico - Google Patents

Imunoensaios de alta sensibilidade e kits para a determinação de peptídeos e proteínas de interesse biológico

Info

Publication number
BRPI0721871A2
BRPI0721871A2 BRPI0721871-0A2A BRPI0721871A BRPI0721871A2 BR PI0721871 A2 BRPI0721871 A2 BR PI0721871A2 BR PI0721871 A BRPI0721871 A BR PI0721871A BR PI0721871 A2 BRPI0721871 A2 BR PI0721871A2
Authority
BR
Brazil
Prior art keywords
immunoans
kits
proteins
high sensitivity
biological interest
Prior art date
Application number
BRPI0721871-0A2A
Other languages
English (en)
Inventor
J Manuel Sarasa Barrio
Original Assignee
Araclon Biotech Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38544110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0721871(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Araclon Biotech Sl filed Critical Araclon Biotech Sl
Publication of BRPI0721871A2 publication Critical patent/BRPI0721871A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0721871-0A2A 2007-08-02 2007-12-05 Imunoensaios de alta sensibilidade e kits para a determinação de peptídeos e proteínas de interesse biológico BRPI0721871A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380227A EP2020602A1 (en) 2007-08-02 2007-08-02 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest
PCT/EP2007/063334 WO2009015696A1 (en) 2007-08-02 2007-12-05 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest

Publications (1)

Publication Number Publication Date
BRPI0721871A2 true BRPI0721871A2 (pt) 2014-02-18

Family

ID=38544110

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0721871-0A2A BRPI0721871A2 (pt) 2007-08-02 2007-12-05 Imunoensaios de alta sensibilidade e kits para a determinação de peptídeos e proteínas de interesse biológico

Country Status (23)

Country Link
US (2) US20090035790A1 (pt)
EP (2) EP2020602A1 (pt)
JP (1) JP5657382B2 (pt)
KR (1) KR101461538B1 (pt)
CN (1) CN101861521B (pt)
AR (1) AR064186A1 (pt)
AT (1) ATE533059T1 (pt)
AU (1) AU2007357025B2 (pt)
BR (1) BRPI0721871A2 (pt)
CA (1) CA2689024C (pt)
CL (1) CL2007003513A1 (pt)
CY (1) CY1112553T1 (pt)
DK (1) DK2183599T3 (pt)
ES (1) ES2377151T3 (pt)
HR (1) HRP20120020T1 (pt)
IL (1) IL202598A (pt)
MX (1) MX2009013009A (pt)
PL (1) PL2183599T3 (pt)
PT (1) PT2183599E (pt)
RS (1) RS52124B (pt)
RU (1) RU2461837C2 (pt)
SI (1) SI2183599T1 (pt)
WO (1) WO2009015696A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011033046A1 (en) 2009-09-18 2011-03-24 Probiodrug Ag Novel assay for the detection of amyloid beta peptides
BR112012014060B8 (pt) * 2009-12-11 2021-07-27 Araclon Biotech Sl método para o diagnóstico da doença de alzheimer em um sujeito, para detecção da disfunção cognitiva branda ou para diferenciar a doença de alzheimer da disfunção cognitiva branda
CN102192985A (zh) * 2010-03-18 2011-09-21 上海依科赛生物制品有限公司 一种人体β淀粉样蛋白试剂盒
KR101352670B1 (ko) * 2010-06-15 2014-01-17 울산대학교 산학협력단 알츠하이머 전구단백질 분비 펩타이드의 축적물을 포함하는 뇌 노화 감별 진단 마커
EP2556378B1 (en) * 2010-07-26 2016-05-18 SNU R & DB Foundation Real-time monitoring of depletion of high-abundance blood proteins or recovery of low-abundance blood proteins by uv spectrometry
WO2012054333A2 (en) * 2010-10-20 2012-04-26 Merck Sharp & Dohme Corp. Methods for identifying inhibitors of abeta42 oligomers
EP2511296A1 (en) * 2011-04-12 2012-10-17 Araclón Biotech, S. L. Antibody, kit and method for determination of amyloid peptides
US20140086836A1 (en) * 2011-05-03 2014-03-27 Mental Health Research Institute Method for detection of a neurological disease
JP6231263B2 (ja) * 2012-07-17 2017-11-15 株式会社島津製作所 アフィニティ支持体及びそれを用いた物質の捕捉方法
JP7434144B2 (ja) * 2018-02-27 2024-02-20 株式会社島津製作所 ＡＰＰ６６９－ｘのＮ末端を特異的に認識する抗体、及び免疫測定法
JP7629278B2 (ja) * 2020-06-25 2025-02-13 シスメックス株式会社 Ａβペプチドを測定するための抗体セット、Ａβペプチドの測定方法及び試薬キット
CN113884683A (zh) * 2020-07-30 2022-01-04 山东京济生物工程有限公司 一种快速检测Aβ42的双抗体夹心ELISA试剂盒
CN114966047A (zh) * 2022-05-10 2022-08-30 上海科华生物工程股份有限公司 一种检测阿尔茨海默病的化学发光试剂盒及其制备方法
CN115932241A (zh) * 2022-12-30 2023-04-07 深圳市天大生物医疗器械有限公司 一种Aβ1-42检测用检测试剂卡及其制备方法与应用
CN118294655A (zh) * 2024-04-12 2024-07-05 上海硅羿生物技术有限公司 一种用于Aβ40/42免疫层析联合定量检测的试剂条及其制备方法
CN118359697A (zh) * 2024-04-29 2024-07-19 上海硅羿生物技术有限公司 β淀粉样蛋白40及β淀粉样蛋白42特异识别多肽及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811310A (en) * 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
AU7121191A (en) * 1990-02-26 1991-10-10 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for alzheimer's disease
US7427392B1 (en) * 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
DE69928809T2 (de) * 1998-07-03 2006-08-31 Innogenetics N.V. Differentielle diagnose von neurodegeneration
AU2001269127A1 (en) * 2000-07-06 2002-01-14 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel app mutation associated with an unusual alzheimer's disease pathology
EP1371986A1 (en) * 2002-06-06 2003-12-17 ABETA GmbH Diagnosis of Alzheimer's disease based on the hAbeta42:hAbeta40 ratio
TWI306458B (en) * 2003-05-30 2009-02-21 Elan Pharma Int Ltd Humanized antibodies that recognize beta amyloid peptide
EP1879613B1 (en) * 2005-05-05 2011-11-30 Merck Sharp & Dohme Corp. Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease

Also Published As

Publication number Publication date
CN101861521B (zh) 2014-03-12
SI2183599T1 (sl) 2012-03-30
WO2009015696A1 (en) 2009-02-05
PL2183599T3 (pl) 2012-04-30
CY1112553T1 (el) 2016-02-10
EP2183599A1 (en) 2010-05-12
ES2377151T3 (es) 2012-03-22
KR101461538B1 (ko) 2014-11-14
IL202598A (en) 2015-10-29
EP2183599B1 (en) 2011-11-09
US20090035790A1 (en) 2009-02-05
AR064186A1 (es) 2009-03-18
CA2689024A1 (en) 2009-02-05
HRP20120020T1 (hr) 2012-03-31
CA2689024C (en) 2015-02-24
KR20100046168A (ko) 2010-05-06
JP5657382B2 (ja) 2015-01-21
RU2009143671A (ru) 2011-05-27
DK2183599T3 (da) 2012-02-27
ATE533059T1 (de) 2011-11-15
AU2007357025A1 (en) 2009-02-05
JP2010535328A (ja) 2010-11-18
PT2183599E (pt) 2012-02-13
US20190178899A1 (en) 2019-06-13
RU2461837C2 (ru) 2012-09-20
CL2007003513A1 (es) 2009-02-06
CN101861521A (zh) 2010-10-13
EP2020602A1 (en) 2009-02-04
MX2009013009A (es) 2010-03-29
IL202598A0 (en) 2010-06-30
RS52124B (sr) 2012-08-31
AU2007357025B2 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
BRPI0721871A2 (pt) Imunoensaios de alta sensibilidade e kits para a determinação de peptídeos e proteínas de interesse biológico
EP2158328A4 (en) FAST PROTEIN MARKING AND ANALYSIS
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
PT2169387E (pt) Método multiparamétrico de alta sensibilidade para a análise de eventos raros numa amostra biológica
EP2232271A4 (en) SCANNING ANALYZER FOR SINGLE MOLECULAR DETECTION AND METHOD FOR ITS APPLICATION
BRPI1015211A2 (pt) cartucho de teste microfluídico descartável para o bioensaio de analitos
BRPI1006595A2 (pt) tira de teste e método para detectar a presença de um análito em uma amostra
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
EP1924849A4 (en) ELECTROCHEMICAL THERMODYNAMIC MEASURING SYSTEM
BRPI0715346A2 (pt) Detecção de analitos e ácidos nucléicos
BRPI0810520A2 (pt) Identificação de tira de teste utilizando modelos condutivos
EP2013561A4 (en) BINARY PROBES FOR FLUORESCENCE ANALYSIS OF NUCLEIC ACIDS
GB0716038D0 (en) Vibrating microtome with automated measurement of verticle runout
ATE501142T1 (de) Als proteinkinaseinhibitoren geeignete phenylacetamide
EP2199814A4 (en) MAGNETIC IMPEDANCE ELEMENT AND MAGNETIC IMPEDANCE SENSOR
BRPI0821397A2 (pt) uso de um material calibrador, método para calibrar um imunoensaio para a detecção de auto-anticorpos, série de padrões de calibração, kit de imunoensaio, e método para quantificar a quantidade de proteina ligada a uma superficie sólida
BRPI0820721A2 (pt) Reagentes e métodos para detectar analitos
BR112012011055A2 (pt) reagente de calibração metodo para gerar uma curva padrão metodo pata qualificar a concetração de uma proteina metodo para determinar o limite inferior de detecção de um reagente de afinidade de interesse metodo para determinar a sensibilidade do reagente de afinidade de interesse metodo para determinar a faixa dinamica de um reagente de afinidade de interesse metodo para determinar a especialidade de um reagente de afinidade de interesse uso do reagente de calibração e proteinas peptideos metodos e uso
BRPI0907864A2 (pt) Identificação de proteínas de ligação específicas para antígenos ou ligandos
EP2233927A4 (en) METHOD FOR MEASURING ENDOTOXIN AND REAGENT KIT FOR MEASURING ENDOTOXIN
FI20075191A0 (fi) Väline ja menetelmä analyysiä varten
DK1904627T3 (da) Fremgangsmåde til fremstilling af prrs-virus og proteiner og diagnostiske testkits til detektion deraf
BRPI0912676A2 (pt) métodos de análise de material e de inspeção ultra-sônica de um objeto
DE602007010553D1 (de) NMR-Spektrometer und Verfahren zur NMR-Messung
DE112004002986A5 (de) Prüfanlage zur zerstörungsfreien Materialprüfung

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25G Requested change of headquarter approved

Owner name: ARACLON BIOTECH S.L. (ES)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25G Requested change of headquarter approved

Owner name: ARACLON BIOTECH S.L. (ES)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]

Free format text: REFERENTE AO DESPACHO 7.1 PUBLICADO NA RPI NO 2496 (06/11/2018)

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time